A Randomized Double-Blind Trial of TQB2450 with or Without Anlotinib in Pretreated Driver-Negative Non-Small Cell Lung Cancer.
Lung Cancer（2023）
Key words
Non -small cell lung cancer,Driver gene mutation,Programmed death-ligand 1 (PD-L1),Monoclonal antibody,TQB2450,Anlotinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined